Page 297 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 297

CHAPTER 16  Histamine, Serotonin, & the Ergot Alkaloids     283


                    TABLE 16–2  Some H  antihistaminic drugs in clinical use.
                                         1
                     Drugs                     Usual Adult Dose  Anticholinergic Activity  Comments
                                                         FIRST-GENERATION ANTIHISTAMINES
                     Ethanolamines
                     Carbinoxamine (Clistin)   4–8 mg            +++                 Slight to moderate sedation
                     Dimenhydrinate (salt of   50 mg             +++                 Marked sedation; anti-motion sickness activity
                     diphenhydramine) (Dramamine)
                     Diphenhydramine (Benadryl, etc)  25–50 mg   +++                 Marked sedation; anti-motion sickness activity
                     Piperazine derivatives
                     Hydroxyzine (Atarax, etc)  15–100 mg        nd                  Marked sedation
                     Cyclizine (Marezine)      25–50 mg          —                   Slight sedation; anti-motion sickness activity
                     Meclizine (Bonine, etc)   25–50 mg          —                   Slight sedation; anti-motion sickness activity
                     Alkylamines
                     Brompheniramine (Dimetane, etc)  4–8 mg     +                   Slight sedation
                     Chlorpheniramine (Chlor-Trimeton,   4–8 mg  +                   Slight sedation; common component of OTC “cold”
                     etc)                                                            medication
                     Phenothiazine derivative
                     Promethazine (Phenergan, etc)  10–25 mg     +++                 Marked sedation; antiemetic; α-block
                     Miscellaneous
                     Cyproheptadine (Periactin, etc)  4 mg       +                   Moderate sedation; significant antiserotonin activity;
                                                                                     mixed evidence for use as an appetite stimulant
                                                        SECOND-GENERATION ANTIHISTAMINES
                     Piperidine
                     Fexofenadine (Allegra, etc)  60 mg          —
                     Miscellaneous
                     Loratadine (Claritin, etc),   10 mg (desloratadine,   —         Longer action; used at 5 mg dosage
                     desloratadine (Clarinex)  5 mg)
                     Cetirizine (Zyrtec, etc)  5–10 mg           —
                    nd, no data found.

                    drug group. Nevertheless, its structure resembles that of the pheno-  CLINICAL PHARMACOLOGY OF
                    thiazine antihistamines, and it is a potent H -blocking agent.  H -RECEPTOR ANTAGONISTS
                                                   1
                                                                           1
                    7.  Local anesthesia—Several first-generation H  antagonists
                                                           1
                    are potent local anesthetics. They block sodium channels in excit-  Clinical Uses
                    able membranes in the same fashion as procaine and lidocaine.   First-generation H -receptor blockers are still commonly used
                                                                                       1
                    Diphenhydramine and promethazine are actually more potent   over-the-counter drugs.  The prevalence of allergic conditions
                    than procaine as local anesthetics. They are occasionally used to   and the relative safety of the drugs contribute to this heavy use.
                    produce local anesthesia in patients allergic to conventional local   However, the fact that they do cause sedation contributes to heavy
                    anesthetic drugs. A small number of these agents also block potas-  prescribing as well as over-the-counter use of second-generation
                    sium channels; this action is discussed below (see Toxicity).  antihistamines.

                    8. Other actions—Certain H  antagonists, eg, cetirizine, inhibit
                                            1
                    mast cell release of histamine and some other mediators of inflam-  A. Allergic Reactions
                    mation. This action is not due to H -receptor blockade and may   The H  antihistaminic agents are often the first drugs used to
                                                                              1
                                                1
                    reflect an H -receptor effect (see below). The mechanism is not   prevent or treat the symptoms of allergic reactions. In  allergic
                              4
                    fully understood but could play a role in the beneficial effects of   rhinitis (hay fever), the H  antagonists are second-line drugs
                                                                                               1
                    these drugs in the treatment of allergies such as rhinitis. A few   after glucocorticoids administered by nasal spray. In urticaria, in
                    H  antagonists (eg, terfenadine, acrivastine) have been shown to   which histamine is the primary mediator, the H 1  antagonists are
                      1
                    inhibit the P-glycoprotein transporter found in cancer cells, the   the drugs of choice and are often quite effective if given before
                    epithelium of the gut, and the capillaries of the brain. The signifi-  exposure. However, in bronchial asthma, which involves several
                    cance of this effect is not known.                   mediators, the H  antagonists are largely ineffective.
                                                                                      1
   292   293   294   295   296   297   298   299   300   301   302